Evolving superantigens of Staphylococcus aureus

FEMS Immunology and Medical Microbiology

Volumn 27, Issue 1, 2000, Pages 1-7

  Ulrich, Robert G ^a  

^a UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

Author keywords

Conjugate vaccine; Intranasal immunization; Lipooligosaccharide; Nontypeable Haemophilus influenzae

Indexed keywords

HLA DR ANTIGEN; POLYPEPTIDE; STAPHYLOCOCCUS ENTEROTOXIN A; SUPERANTIGEN; T LYMPHOCYTE RECEPTOR; VIRULENCE FACTOR;

AUTOIMMUNE DISEASE; AUTOIMMUNITY; FOOD POISONING; PRIORITY JOURNAL; REVIEW; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; TOXIC SHOCK SYNDROME; VIRULENCE;

EID: 0033989564     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1574-695X.2000.tb01404.x     Document Type: Article

References (44)

1. Berman S. Otitis media in children. New Engl. J. Med. 332:1995;1560-1565.
2. Murphy T.F., Bernstein J.M., Dryja D.M., Campagnari A.A., Apicella M.A. Outer membrane protein and lipooligosaccharide analysis of paired nasopharyngeal and middle ear isolates in otitis media due to nontypable Haemophilus influenzae: pathogenetic and epidemiological observations. J. Infect. Dis. 156:1987;723-731.
3. Brook I., Gober A.E. Microbiologic characteristics of persistent otitis media. Arch. Otolaryngol. Head Neck Surg. 124:1998;1350-1352.
4. Commisso R., Romero O.F., Montanaro P.B., Romero M.F., Romero D.R. Acute otitis media: bacteriology and bacterial resistance in 205 pediatric patients. Int. J. Pediatr. Otorhinolaryngol. 56:2000;23-31.
5. Bernstein J.M., Faden H.F., Dryja D.M., Wactawski W.J. Micro-ecology of the nasopharyngeal bacterial flora in otitis-prone and non-otitis-prone children. Acta Otolaryngol. 113:1993;88-92.
6. Faden H., Duffy L., Wasielewski R., Wolf J., Krystofik D., Tung Y. Relationship between nasopharyngeal colonization and the development of otitis media in children. J. Infect. Dis. 175:1997;1440-1445.
7. Williams R.C., Gibbons R.J. Inhibition of bacterial adherence by secretory immunoglobulin A: a mechanism of antigen disposal. Science. 177:1972;697-699.
8. Cripps A.W., Taylor D.C., Wallace F.J., Clancy R.L. Respiratory immunity stimulated by intestinal immunization with purified nontypeable Haemophilus influenzae antigens. J. Infect. Dis. 165:1992;S199-S201.
9. Kyd J.M., Cripps A.W. Potential of a novel protein, OMP26, from nontypeable Haemophilus influenzae to enhance pulmonary clearance in a rat model. Infect. Immun. 66:1998;2272-2278.
10. Kyd J.M., Dunkley M.L., Cripps A.W. Enhanced respiratory clearance of nontypeable Haemophilus influenzae following mucosal immunization with P6 in a rat model. Infect. Immun. 63:1995;2931-2940.
11. Kurono Y., Shigemi H., Kodama S., Mogi G. Effects of oral and systemic immunization on nasopharyngeal clearance of nontypeable Haemophilus influenzae in BALB/c mice. Laryngoscope. 106:1996;614-618.
12. Kurono Y., Yamamoto M., Fujihashi K., Kodama S., Suzuki M., Mogi G., McGhee J.R., Kiyono H. Nasal immunization induces Haemophilus influenzae-specific Th1 and Th2 responses with mucosal IgA and systemic IgG antibodies for protective immunity. J. Infect. Dis. 180:1999;122-132.
13. Hotomi M., Saito T., Yamanaka N. Specific mucosal immunity and enhanced nasopharyngeal clearance of nontypeable Haemophilus influenzae after intranasal immunization with outer membrane protein P6 and cholera toxin. Vaccine. 16:1998;1950-1956.
14. Kodama S., Suenaga S., Hirano T., Suzuki M., Mogi G. Induction of specific immunoglobulin A and Th2 immune responses to P6 outer membrane protein of nontypeable Haemophilus influenzae in middle ear mucosa by intranasal immunization. Infect. Immun. 68:2000;2294-2300.
15. Sabirov A., Kodama S., Hirano T., Suzuki M., Mogi G. Intranasal immunization enhances clearance of nontypeable Haemophilus influenzae and reduces stimulation of tumor necrosis factor alpha production in the murine model of otitis media. Infect. Immun. 69:2001;2964-2971.
16. DeMaria T.F., Apicella M.A., Nichols W.A., Leake E.R. Evaluation of the virulence of nontypeable Haemophilus influenzae lipooligosaccharide htrB and rfaD mutants in the chinchilla model of otitis media. Infect. Immun. 65:1997;4431-4435.
17. Barenkamp S.J., Bodor F.F. Development of serum bactericidal activity following nontypable Haemophilus influenzae acute otitis media. Pediatr. Infect. Dis. J. 9:1990;333-339.
18. Ueyama T., Gu X.X., Tsai C.M., Karpas A.B., Lim D.J. Identification of common lipooligosaccharide types in isolates from patients with otitis media by monoclonal antibodies against nontypeable Haemophilus influenzae 9274. Clin. Diagn. Lab. Immunol. 6:1999;96-100.
19. McGehee J.L., Radolf J.D., Toews G.B., Hansen E.J. Effect of primary immunization on pulmonary clearance of nontypable Haemophilus influenzae. Am. J. Respir. Cell. Mol. Biol. 1:1989;201-210.
20. Mansson M., Bauer S.H., Hood D.W., Richards J.C., Moxon E.R., Schweda E.K. A new structural type for Haemophilus influenzae lipopolysaccharide. Structural analysis of the lipopolysaccharide from nontypeable Haemophilus influenzae strain 486. Eur. J. Biochem. 268:2001;2148-2159.
21. Schweda E.K., Li J., Moxon E.R., Richards J.C. Structural analysis of lipopolysaccharide oligosaccharide epitopes expressed by non-typeable Haemophilus influenzae strain 176. Carbohydr. Res. 337:2002;409-420.
22. Mansson M., Hood D.W., Li J., Richards J.C., Moxon E.R., Schweda E.K. Structural analysis of the lipopolysaccharide from nontypeable Haemophilus influenzae strain 1003. Eur. J. Biochem. 269:2002;808-818.
23. Phillips N.J., Apicella M.A., Griffiss J.M., Gibson B.W. Structural characterization of the cell surface lipooligosaccharides from a nontypable strain of Haemophilus influenzae. Biochemistry. 31:1992;4515-4526.
24. Rahman M.M., Gu X.X., Tsai C.M., Kumar Kolli V.S., Russell W.C. The structural heterogeneity of the lipooligosaccharide (LOS) expressed by pathogenic non-typeable Haemophilus influenzae strain NTHi 9274. Glycobiology. 9:1999;1371-1380.
25. Campagnari A.A., Gupta M.R., Dudas K.C., Murphy T.F., Apicella M.A. Antigenic diversity of lipooligosaccharides of nontypable Haemophilus influenzae. Infect. Immun. 55:1987;882-887.
26. Patrick C.C., Kimura A., Jackson M.A., Hermanstorfer L., Hood A., McCracken G.H. Jr., Hansen E.J. Antigenic characterization of the oligosaccharide portion of the lipooligosaccharide of nontypable Haemophilus influenzae. Infect. Immun. 55:1987;2902-2911.
27. Gu X.X., Tsai C.M., Ueyama T., Barenkamp S.J., Robbins J.B., Lim D.J. Synthesis, characterization, and immunologic properties of detoxified lipooligosaccharide from nontypeable Haemophilus influenzae conjugated to proteins. Infect. Immun. 64:1996;4047-4053.
28. Gu X.X., Sun J., Jin S., Barenkamp S.J., Lim D.J., Robbins J.B., Battey J. Detoxified lipooligosaccharide from nontypeable Haemophilus influenzae conjugated to proteins confers protection against otitis media in chinchillas. Infect. Immun. 65:1997;4488-4493.
29. Sun J., Chen J., Cheng Z., Robbins J.B., Battey J.F., Gu X.X. Biological activities of antibodies elicited by lipooligosaccharide based-conjugate vaccines of nontypeable Haemophilus influenzae in an otitis media model. Vaccine. 18:2000;1264-1272.
30. Gu X.X., Tsai C.M., Apicella M.A., Lim D.J. Quantitation and biological properties of released and cell-bound lipooligosaccharides from nontypeable Haemophilus influenzae. Infect. Immun. 63:1995;4115-4120.
31. Asanuma H., Thompson A.H., Iwasaki T., Sato Y., Inaba Y., Aizawa C., Kurata T., Tamura S. Isolation and characterization of mouse nasal-associated lymphoid tissue. J. Immunol. Methods. 202:1997;123-131.
32. Gu X.X., Tsai C.M., Karpas A.B. Production and characterization of monoclonal antibodies to type 8 lipooligosaccharide of Neisseria meningitidis. J. Clin. Microbiol. 30:1992;2047-2053.
33. Bergquist C., Lagergard T., Holmgren J. Antibody responses in serum and lung to intranasal immunization with Haemophilus influenzae type b polysaccharide conjugated to cholera toxin B subunit and tetanus toxoid. Apmis. 106:1998;800-806.
34. Jakobsen H., Saeland E., Gizurarson S., Schulz D., Jonsdottir I. Intranasal immunization with pneumococcal polysaccharide conjugate vaccines protects mice against invasive pneumococcal infections. Infect. Immun. 67:1999;4128-4133.
35. Shen X., Lagergard T., Yang Y., Lindblad M., Fredriksson M., Holmgren J. Systemic and mucosal immune responses in mice after mucosal immunization with group B streptococcus type III capsular polysaccharide-cholera toxin B subunit conjugate vaccine. Infect. Immun. 68:2000;5749-5755.
36. Wagner D.K., Clements M.L., Reimer C.B., Synder M., Nelson D.L., Murphy B.R. Analysis of immunoglobulin G antibody responses after administration of live and inactivated influenza A vaccine indicates that nasal wash immunoglobulin G is a transudate from serum. J. Clin. Microbiol. 25:1987;559-562.
37. Ogra P.L., Bernstein J.M., Yurchak A.M., Coppola P.R., Tomasi T.B. Jr. Characteristics of secretory immune system in human middle ear: implications in otitis media. J. Immunol. 112:1974;488-495.
38. Sloyer J.L. Jr., Howie V.M., Ploussard J.H., Schiffman G., Johnson R.B. Jr. Immune response to acute otitis media: association between middle ear fluid antibody and the clearing of clinical infection. J. Clin. Microbiol. 4:1976;306-308.
39. Kauppi-Korkeila M., van Alphen L., Madore D., Saarinen L., Kayhty H. Mechanism of antibody-mediated reduction of nasopharyngeal colonization by Haemophilus influenzae type b studied in an infant rat model. J. Infect. Dis. 174:1996;1337-1340.
40. Shurin P.A., Pelton P.I., Tager I.B., Kasper D.L. Bactericidal antibody and susceptibility to otitis media cause by nontypeable strains of Haemophilus influenzae. J. Pediatr. 97:1980;364-369.
41. Vogel L., van Alphen L., Geluk F., Jansen H., Dankert J. Opsono-phagocytosis of non-encapsulated Haemophilus influenzae. Adv. Exp. Med. Biol. 371A:1995;695-699.
42. Swords W.E., Buscher B.A., Steeg li K.V., Preston A., Nichols W.A., Weiser J.N., Gibson B.W., Apicella M.A. Nontypeable Haemophilus influenzae adhere to and invade human bronchial epithelial cells via an interaction of lipooligosaccharide with the PAF receptor. Mol. Microbiol. 37:2000;13-27.
43. Neuberger M.S., Rajewsky K. Activation of mouse complement by monoclonal mouse antibodies. Eur. J. Immunol. 11:1981;1012-1016.
44. Wu T.H., Gu X.X. Outer membrane proteins as a carrier for detoxified lipooligosaccharide conjugate vaccines for nontypeable Haemophilus influenzae. Infect. Immun. 67:1999;5508-5513.